Five enzyme-linked immunosorbent assay systems were adapted for serotyping human rotavirus strains and were compared with a sensitive complement fixation test in terms of specificity and sensitivity. The assays differed mainly with regard to the antibody systems involved in the double sandwich. Serotype differentiation of 34 rotavirus strains was achieved by determining a neutralization endpoint titer, either with a constant antiserum-varying antigen dilution method or vice versa. The procedure which proved to be highly specific and sensitive was one with two type-specific hyperimmune sera (enzyme-linked immunosorbent assay system 5) instead of only one, as in the four other systems.
Five enzyme-linked immunosorbent assay systems were adapted for serotyping human rotavirus strains and were compared with a sensitive complement fixation test in terms of specificity and sensitivity. The assays differed mainly with regard to the antibody systems involved in the double sandwich. Serotype differentiation of 34 rotavirus strains was achieved by determining a neutralization endpoint titer, either with a constant antiserum-varying antigen dilution method or vice versa. The procedure which proved to be highly specific and sensitive was one with two type-specific hyperimmune sera (enzyme-linked immunosorbent assay system 5) instead of only one, as in the four other systems.
Since human rotavirus strains produce no cytopathic effect in tissue culture, conventional neutralization tests cannot be used to study antigenic differences in the outer capsid layer (1) . Recently, however, we were able to distinguish two serotypes of human rotavirus by complement fixation (CF) and immune electron microscopy (5) . The latter technique is cumbersome and is not applicable to routine serotyping of large series of rotavirus-positive stools, whereas the former is not sensitive enough for specimens with a low antigen fiiter.
To study the epidemiology of rotavirus serotypes, we have modified the enzyme-linked inmunosorbent assay (ELISA) procedure described by Yolken et al. (2) for the detection of this virus in stools.
MATERIALS AND METHODS
Specimens. During the winter of 1977 to 1978, we collected fecal specixnens from infants and children with a diarrheal illness and also from neonates with or without gastroenteritis. All samples in which rotavirus was found by the ELISA technique for antigen detection (2) were stored at -20°C.
Preparation of hyperimmune sera. Type-specific immune sera (IS, and IS2) were obtained by immunizing guinea pigs and specific pathogen-free (SPF) rabbits with purified rotavirus types 1 and 2 by the procedure previously described (5) . Briefly, two rotavirus-positive stools for which the serotype had been established by CF, and which were known to contain numerous complete virions (3101' particles per g of feces) were selected for purification. A 30% stool suspension (wt/vol) was prepared which was then centrifuged twice at low speed (1,000 x g for 10 min). The supematant fluid was recovered and checked for rotavirus. Both preparations gave a titer >a32 by the sensitive CF technique described below and showed 20 to 50 particles per grid square when examined with an electron microscope (negative staining) at a magnification of x 25,000.
A 0.5-mi volume of each of the specimens was subjected to rate zonal centrifugation through a 4.5 ml, 60 to 45 to 30% sucrose gradient at 100,000 x g for 2.5 h. The fractions with a density of 1.22 containing double-shelled rotavirus particles were collected and again checked by electron microscopy. There were no incomplete or broken rotaviruses observed in either preparation. After purification, 1 ml of each fraction with density 1.22 was mixed with 1 ml of Freund complete adjuvant and used for immunization.
Guinea pigs and SPF rabbits were pretested for the presence of rotavirus antibodies by an ELISA blocking assay (3). The majority (>90%) of a stock of guinea pigs bred in our own animal house, as well as the SPF rabbits, kindly provided by the Smith Kline R.I.T. Cie (B-1330 Rixensart, Belgium), did not have preexisting antibodies, at least at a serum dilution of 1:4. We could therefore easily select animals for immunization.
The aninals received three subcutaneous injections, each of 0.6 ml, on days 0, 7, and 21. Two weeks after the last inoculation (day 35), the animals were bled by heart puncture. The sera thus obtained were designated as IS, (nonabsorbed; type-specific serum against human serotype 1) and IS2 (nonabsorbed; typespecific serum against human serotype 2) and contained 1,024 CF type-specific antibody units, whereas both reacted with Nebraska calf diarrhea virus (NCDV) at a dilution of 128. Attempts were made to increase the specificity of the hyperimmune sera by first absorbing them with NCDV. A concentrated suspension was prepared from NCDV grown on BGM cells (Microbiological Associates, Bethesda, Md.) in the presence of trypsin (10 ltg/ml of maintenance medium). These cells were previously shown to be an excellent host system (unpublished data) in which a clear-cut viral cytopathic effect appeared after 24 h.
The infected culture was twice frozen and thawed after complete dissociation of the monolayer, which generally occurred within 2 or 3 days. After low-speed centrifugation (1,000 x g for 10 min) to eliminate the cellular debris, the supernatant fluid was subjected to ultracentrifugation (100,000 x g for 2.5 h). The pellet serum, and 1 ml of each hyperimmune serum (IS, and IS2), diluted to contain 64 type-specific antibody units, was mixed with 3 ml of the concentrated NCDV and incubated at 4°C overnight. The next day the mixture was layered on a 40% sucrose cushion (wt/vol) and subjected to high-speed centrifugation (100,000 x g for 2.5 h) to remove the rotavirus antigen-antibody complexes. This procedure yielded 4 ml of absorbed hyperimmune serum with a type-specific CF antibody titer of 1:16.
We also prepared a group-specific inumune serum (IS) against human rotavirus by immunizing an SPF rabbit with the concentrated NCVD suspension mentioned above previously purified through a 60 to 45 to 30% sucrose gradient.
CF. The CF technique for detection of rotavirus in stool extracts with IS has been described elsewhere (6) . For ELISA. To differentiate human rotavirus strains we modified the basic ELISA described by Yolken et al. (2) . Based upon determining the endpoint titer of the hyperimmune sera against a constant amount of viral antigen, or vice versa, we developed five typespecific rotavirus ELISA methods. The origin and the concentrations of the antisera and the enzyme-labeled conjugates are shown in Table 1 .
ELISA system 3 was in fact analogous to the one described by Yolken et In a second experiment, 12 rotavirus-positive stools were typed by CF and ELISA system 4, in which the endpoint titer was expressed as a serial antigen dilution. Initially, the antigen titer of the various strains was measured with IS to compare the relative sensitivity of the two techniques. Earlier studies had shown that low-titered preparations could not be typed by the CF procedure unless they were previously concentrated.
In further experiments attempts were made to serotype human rotavirus strains by ELISA system 5. Since the 12 strains used in the previous experiment were exhausted, another 17 rotavirus-positive stools were selected, 13 of which had a low group-specific antigen titer (CF titer <1).
RESULTS
Type-specific differentiation of five human rotavirus strains by CF and ELISA 1, 2, or 3 gave identical results (Table 2) . Moreover, differences in neutralizing titer between homologous and heterologous antiserum were about the same in all tests, although slightly greater with the CF. Reading and interpreting the results, however, were much easier with the latter. The endpoint titer was very clear-cut by CF (Fig. 1) Because the difficulty in reading results with the naked eye with ELISA systems 1 and 3 and the relative lack of sensitivity of the ELISA 2 assay, we ran comparative studies between CF and ELISA 4 ( Table 3 ). The ELISA 4 system was more sensitive than CF for the detection of rotavirus antigen, but not for serotype differentiation. The CF technique detected 9 of the 12 strains (antigen titer, >1), and the ELISA 4 detected all 12. However, only the five strains with a CF titer >4 could be typed either with CF or with ELISA.
Type differentiation by visual analysis was much easier to perform with the ELISA 4 system than with the three preceding assays. Indeed, virtually no cross-reactivity was observed. However, for serotyping, sensitivity was not superior to that of the CF. In efforts to increase sensitivity, we developed an ELISA 5 system with two type-specific hyperimmune sera of different origin: the first one, produced in SPF rabbits, was coated onto the microtiter plate, and the second one, obtained from a guinea pig, was used to demonstrate the antigen bound by the former. Results are shown in Table 4 . As would be expected, the type specificity of the four specimens containing the most rotavirus (CF titer >4) could easily be determined. In addition, excellent results were also obtained with lowtitered preparations. Although the difference in neutralizing capacity of IS1 and IS2 was not always as great as that observed with the first four strains mentioned above, we did not encounter real problems in interpretation with lower-titered specimens. The specificity of the assay was sufficiently good that results of serotyping could be read without the use of a spectrophotometer (Fig. 2) . Recently, we also analyzed 33 strains from a maternity unit in Brussels in which 60% of the newborns became infected with rotavirus during May 1979. All the specimens could be differentiated with the ELISA system 5, and serotyping revealed that 100% of the infections were due to type 2.
Finally, the following observation is noteworthy: the origin of the six type 1 strains shown in Table 4 was checked retrospectively and it was found that they all originated from children with a nosocomial rotavirus infection who had been hospitalized at nearly the same time in the same pediatric ward.
